紧密封锁可以改善抗Mycobacterium结核病免疫力
Jingyu Zhou1, Qingluan Yang1, Haoxin Xu1
1Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
PLoS pathogens
|June 17, 2025
概括
用免疫球蛋白和免疫受体氨酸基抑制动机域 (TIGIT) 阻断T细胞免疫受体可以提高CD8+T细胞对结核病的免疫力. TIGIT阻塞增强T细胞功能,促进患者和小鼠模型中的细菌清除.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 结核病研究 结核病研究
背景情况:
- 免疫检查点封锁显示在癌症中具有治疗效益,但其在传染病中的作用尚不清楚.
- 具有免疫球蛋白和免疫受体氨酸基抑制动机域的T细胞免疫受体 (TIGIT) 是T细胞表达的免疫检查点受体.
- 活跃的Mycobacterium结核病感染会影响T细胞免疫力,但TIGIT的作用尚不清楚.
研究的目的:
- 调查阻断TIGIT是否可以提高T细胞在活跃结核病中的免疫力.
- 评估结核病患者的TIGIT表达及其与疾病严重程度的相关性.
- 评估TIGIT封锁在结核病中的治疗潜力.
主要方法:
- 在结核病患者的周围血液和肺病变中评估了TIGIT表达.
- 使用流细胞计和转录组分析分析了TIGIT+和TIGIT-CD8+T细胞子集的功能状态.
- 研究了TIGIT阻断对体外CD8+T细胞功能和结核病小鼠模型中的细菌负载的影响.
主要成果:
- 在活跃结核病患者中,TIGIT在CD8+ T细胞上显著升级,与疾病严重程度相关.
- 与其他感染相比,肺结核病变中的TIGIT表达率更高.
- 在小鼠中,TIGIT阻塞增强了CD8+T细胞效应器功能,并降低了细菌负担.
结论:
- 激活的CD8+ T细胞在活性结核病中表达TIGIT,限制T细胞免疫力.
- TIGIT 阻塞增强了 CD8+ T 细胞功能,并促进了 Mycobacterium 结核病的清除.
- TIGIT封锁代表了一种潜在的新型结核病治疗策略.
更多相关视频
相关概念视频
Pulmonary Tuberculosis V
249
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
249
Pulmonary Tuberculosis IV
212
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
212
Pulmonary Tuberculosis I
335
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
335
Pulmonary Tuberculosis II
389
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
389
Pulmonary Tuberculosis III
459
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
459
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675


